J. Cadranel

12.5k citations

170 papers · 5.3k indexed · 2 hit papers · h-index 35

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
Infectious Diseases top 1%
- Antifungal resistance and susceptibility

Papers in

Pulmonary and Respiratory Medicine 124
- Lung Cancer Treatments and Mutations 70
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 34
- Lung Cancer Diagnosis and Treatment 28
Oncology 68
- Lung Cancer Research Studies 22
- Colorectal Cancer Treatments and Studies 17
- Viral-associated cancers and disorders 12

Co-authors: François Boué Dominique Costagliola Jean-Marie Lang Christoph Lange Marguerite Guiguet Catherine Beigelman‐Aubry Andrew J. Ullmann George Dimοpoulos
Journals: Journal of Clinical Oncology (16 papers)Annals of Oncology (16 papers)Lung Cancer (10 papers)European Respiratory Journal (8 papers)CHEST Journal (7 papers)
Partner nations: France United States Italy

In The Last Decade

J. Cadranel

162 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features 2015 · 655 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 European Respiratory Journal
2015 European Respiratory Journal

Peers

Countries citing papers authored by J. Cadranel

Since Specialization

Citations

This map shows the geographic impact of J. Cadranel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Cadranel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Cadranel more than expected).

Fields of papers citing papers by J. Cadranel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Cadranel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Cadranel. The network helps show where J. Cadranel may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Cadranel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Cadranel Line = papers co-authored together J. Cadranel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study Lung Cancer ·加藤多恵子, Laurent Greillier, Florian Guisier, Catherine Daniel, R. Descourt, Loïck Galland, Olivier Molinier, C. Decroisette, Alexis B. Cortot, EM Torres, Laurence Gamé, Marie Wislez, Nicolas Cloarec, Horacio Videla, Ya-Li Wu, J. Cadranel, Boris Duchemann, Yoo-Mi Lee, C. Chouaïd, J.B. Auliac	2025	0
2	Prospective validation of in silico clinical trials prediction using an EGFR-mutated NSCLC mechanistic computational disease model. Journal of Clinical Oncology ·M. Duruisseaux, Perrine Masson, 강승휘, Nicolas Girard, J. Cadranel, Aurélie Swalduz, W-H. Chow, Guillaume Bouchard, 俊昭奥山, Kishore Kumar Venkatesan, Jim Bosley, Rahbar Kiyarash, 優子村上, Janusz Zwiazek	2024	1
3	Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases Respirology ·JeoungDu Kim, Arthur Mageau, Marie‐Pierre Debray, Karim Sacré, N. Costedoat‐Chalumeau, É. Hachulla, Y. Uzunhan, Rupert Hoogewerf, J. Cadranel, S. Marchand‐Adam, David Montani, J.L. Solazzi, Martine Reynaud‐Gaubert, Grégoire Prévôt, Guillaume Beltramo, Bruno Crestani, Vincent Cottin, Raphaël Borie, (unknown)	2024	4
4	PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitors Respiratory Medicine and Research ·Daniel Feierstein, Vincent Fallet, Boris Duchemann, Stéphane Jouveshomme, J. Cadranel, C. Chouaïd	2023	5
5	Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging EJNMMI Radiopharmacy and Chemistry ·Fernando Costenaro, Matthieu Delion, Rosa María Riquelme Cortado, 오나랑, Anita Rodenas, Jean‐Noël Talbot, Shinta Dhian Hasna' Atifah, Нехорошева София Сергеевна, Françoise Montravers, J. Cadranel, Aurélie Prignon	2023	4
6	1404P Clinical characteristics and therapeutics sequences of KRAS G12C metastatic non-small cell lung cancer (mNCSLC) patients treated by sotorasib in the French pre-marketing authorization (MA) early access program (cohort temporary authorization of use, cATU) Annals of Oncology ·H. Léna, J. Cadranel, Nicolas Girard, Julien Mazières, 洋一杉田, Adriana Camila Cedeño Quimi, Catanzaro, J.B. Auliac, Olivier Bylicki, 二木紀行, S. Couraud, Fabrice Barlési, Éric Pichon, Federica Cadamuro Morgante, Hamadi Almotlak, Daniel Liens, Khonicheva Nm, Boris Duchemann, Pia Acker, Xavier Quantin	2023	1
7	Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis European Respiratory Journal ·Thomas Maitre, Jonathan Cottenet, C. Godet, Adrien Roussot, Renata Ūkelytė, Владыцкий Алексей Сергеевич, Antoine Parrot, Philippe Bonniaud, Catherine Quantin, J. Cadranel	2021	25
8	Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer Lung Cancer ·Sanjay Popat, Odd Terje Brustugun, J. Cadranel, Enriqueta Felip, Marina Chiara Garassino, Frank Griesinger, Åslaug Helland, Maximilian J. Hochmair, M. Pérol, Amanul Islam, Trevor Pyle, Silvia Novello	2021	13
9	Pyogenic lung abscess in an infectious disease unit: a 20-year retrospective study Therapeutic Advances in Respiratory Disease ·Thomas Maitre, Владыцкий Алексей Сергеевич, Ruxandra Câlin, Ludovic Lassel, Y. H. Chen, Denis Michel, Mohammed Hamidi, A. Zacarias, Charlotte Verdet, Antoine Parrot, J. Cadranel, Gilles Pialoux	2021	14
10	A Severe COVID-19 Pneumonia Revealing a Lepidic Adenocarcinoma: A Diagnostic Challenge during the Pandemic Period American Journal of Respiratory and Critical Care Medicine ·Alexandre Elabbadi, Anne Fajac, Martine Antoine, J. Cadranel, Guillaume Voiriot, Muriel Fartoukh, Aude Gibelin	2021	1
11	Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trial Respiratory Medicine and Research ·Théodora Bejan‐Angoulvant, Jean‐Marc Naccache, Agnès Caille, Raphaël Borie, Hilario Nunès, Marion Ferreira, J. Cadranel, Bruno Crestani, Vincent Cottin, S. Marchand‐Adam	2020	9
12	1349P Lorlatinib for advanced ROS1+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort Annals of Oncology ·Nicolas Girard, Monica Kleinnman, M. Duruisseaux, Virginie Avrillon, Benoît Roch, Josiane Otto, J. Cadranel, 楠智一, Denis Moro‐Sibilot, Thomas Egenod, R. Lamy, Jaafar Bennouna, Gérard Zalcman, Charles Ricordel, Sylvia Díaz-Montenegro, Yuan Jiang Chen, Benjamin Besse, Jeanne Lima de Oliveira, Virginie Westeel, Simon Baldacci	2020	1
13	Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer European Respiratory Review ·J. Cadranel, Anthony Canellas, Elisa Amelia, I.P.J. Shipsey, Antoine Parrot, Jean‐Marc Naccache, A. Lavolé, Anne-Marie Ruppert, Vincent Fallet	2019	69
14	Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial Clinical Lung Cancer ·Jaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, Aurélie Le Thuaut, Radj Gervais, Philippe Masson, M. Marcq, Olivier Molinier, Alexis B. Cortot, D. Debieuvre, J. Cadranel, H. Léna, Denis Moro‐Sibilot, C. Chouaïd, B. Mennecier, T. Urban, Christine Sagan, R. Piegaia, Fabrice Barlési, Marc G. Denis	2019	19
15	Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review Mycopathologia ·C. Godet, Estelle Cateau, Blandine Rammaert, 안치훈, G. Le Moal, Guillaume Béraud, Е.В. Журба, Xavier Iriart, J. Cadranel, (unknown)	2017	24
16	Clinical and biological characteristics of non-small cell lung cancer (NSCLC) harbouring EGFR mutation: Results of the nationwide programme of the French Cooperative Thoracic Intergroup (IFCT) Annals of Oncology ·Charlotte Leduc, Hélène Blons, Benjamin Besse, J.P. Merlio, D. Debieuvre, Antoinette Lemoine, I. Monnet, Damien Pouessel, P. P. Bringuier, M. Poudenx, Isabelle Rouquette, F. Vaylet, Franck Morin, Alexandra Langlais, Élisabeth Quoix, Gérard Zalcman, Denis Moro‐Sibilot, J. Cadranel, Michèle Beau‐Faller, Fabrice Barlési	2016	2
17	RhoB Determines Tumor Aggressiveness in a Murine EGFRL858R-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer Clinical Cancer Research ·Olivier Calvayrac, Anne Pradines, Isabelle Raymond‐Letron, Isabelle Rouquette, Emilie Bousquet, Valérie Lauwers‐Cancès, Thomas Filleron, J. Cadranel, Michèle Beau‐Faller, Juan F. Benfeldt, Julie Milia, Gilles Favre, Julien Mazières	2014	18
18	Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county European Respiratory Journal ·Boris Duchemann, Isabella Annesi‐Maesano, 우미건설, Sin Yu. Leong, Mathilde Neuville, AM Clerke, Luciana Sciumè, Raphaël Borie, A. Mékinian, Marc Mathieu, Bruno Crestani, J. Cadranel, O. Fain, Dominique Valeyre, Hilario Nunès	2013	1
19	Diffuse alveolar hemorrhage in immunocompetent patients: Etiologies and prognosis revisited Respiratory Medicine ·Nicolas de Prost, Antoine Parrot, É. Cuquemelle, C. Picard, Martine Antoine, J Fleury-Feith, Charles Mayaud, Jean‐Jacques Boffa, Muriel Fartoukh, J. Cadranel	2012	61
20	101: Identification of differential pathways in mucinous and non-mucinous subtypes of lung adenocarcinoma suggested new therapeutic strategies Bulletin du Cancer ·Amandine Hurbin, Benoît Busser, Élisabeth Brambilla, Denis Moro‐Sibilot, Martine Antoine, Virginie Poulot, Jean‐Luc Coll, Marie Wislez, J. Cadranel	2010	2

About J. Cadranel

J. Cadranel is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Infectious Diseases, Microbiology and Epidemiology, having authored 170 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (70 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (34 papers), Lung Cancer Diagnosis and Treatment (28 papers), Lung Cancer Research Studies (22 papers), Colorectal Cancer Treatments and Studies (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Antifungal resistance and susceptibility (13 papers) and Viral-associated cancers and disorders (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Infectious Diseases (1.3k citations), Oncology (1.6k citations), Epidemiology (1.7k citations) and Pathology and Forensic Medicine (815 citations). J. Cadranel has collaborated with scholars based in France, United States and Italy. Frequent co-authors include François Boué, Dominique Costagliola, Jean-Marie Lang, Christoph Lange, Marguerite Guiguet, Catherine Beigelman‐Aubry, Andrew J. Ullmann, George Dimοpoulos, Arunaloke Chakrabarti and Florence Ader. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Lung Cancer, European Respiratory Journal and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact